Form 4: Thermo Fisher Scientific Executive Vice President Michael D. Shafer Reports Stock Transactions
SEC Form 4 Filing
Executive Vice President Michael D. Shafer reports stock transactions, including the sale of shares and adjustments to performance-based restricted stock units, according to a Form 4 filing.
Summary
- Michael D. Shafer, an Executive Vice President at Thermo Fisher Scientific, filed a Form 4 detailing changes in beneficial ownership of company stock.
- On February 28, 2025, Shafer disposed of shares to cover tax obligations related to vesting restricted stock units at a price of $528.96 per share.
- These transactions involved the disposal of 244.59, 109.77, and 636.084 shares respectively.
- On March 3, 2025, Shafer sold 1,780 shares at a price of $530.92 per share.
- The filing also reflects a downward adjustment of 349 shares of a performance-based restricted stock unit award granted on February 23, 2022, due to the company's relative total shareholder return (TSR) over the measurement period from January 1, 2022, to December 31, 2024.
- The third tranche was adjusted downward by 30% due to the company's relative TSR.
- The reported transactions were executed under a Rule 10b5-1 trading plan adopted on November 20, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document primarily reports routine stock transactions and adjustments to equity awards. The transactions are part of a pre-arranged plan and the adjustment is based on a pre-defined performance metric.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely watched by investors for insights into management's perspective on the company's performance and future prospects. Rule 10b5-1 plans are frequently used to allow insiders to sell shares without being accused of trading on non-public information.
Comparison to Industry Standards
- Executive compensation structures, including performance-based restricted stock units, are common across the pharmaceutical and scientific instrument industries.
- Companies like Danaher, Agilent, and PerkinElmer also utilize similar equity-based compensation to align executive incentives with shareholder value.
- The vesting schedules and performance metrics tied to these awards vary, but TSR is a frequently used measure.
- Downward adjustments to equity awards based on TSR performance are not uncommon when companies underperform their peers.
Key Dates
| Date | Description |
|---|---|
| February 23, 2022 | Date of grant for performance-based restricted stock unit award. |
| January 1, 2022 December 31, 2024 | Measurement period for the company's relative total shareholder return (TSR). |
| February 22, 2023 | Reporting person reported the acquisition of the performance-based restricted stock unit award. |
| February 28, 2023 | One-third of the shares vested. |
| February 28, 2024 | One-third of the shares vested. |
| November 20, 2024 | Date of adoption of Rule 10b5-1 trading plan. |
| February 28, 2025 | Date of stock disposals related to tax obligations and final vesting of restricted stock units. |
| March 3, 2025 | Date of stock sale. |
| March 4, 2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.